openPR Logo
Press release

Global Controlled Drug Delivery Market & Controlled Drug Delivery Clinical Trial Outlook 2022

07-07-2017 08:46 AM CET | Health & Medicine

Press release from: Kuick Resarch

Global Controlled Drug Delivery Market & Controlled Drug

With significant paradigm shifts in drug discovery and development, the industry is also gearing up to adopt alternative drug delivery strategies in order to further facilitate drug development. Opportunities have significantly increased in the last few years. Pharmaceutical companies are collaborating with drug delivery firms to effectively target patient concerns. Many different drug delivery systems have been designed and evaluated, and a large number of strategies for site-specific drug targeting to pathological tissues have been explored.

Incorporating an existing medicine into a new drug delivery system can significantly improve its performance in terms of efficacy, safety, and improved patient compliance. The need for delivering drugs to patients efficiently and with fewer side effects has prompted pharmaceutical companies to engage in the development of new drug delivery systems.

Advantages of advanced drug delivery systems over traditional systems are the ability to deliver a drug more selectively to a specific site; easier, more accurate, less frequent dosing; decreased variability in systemic drug concentrations; absorption that is more consistent with the site and mechanism of action; and reductions in toxic metabolites. Providing control over the drug delivery can be the most important factor at times when traditional oral or injectable drug formulations cannot be used.

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

Download Report: https://www.kuickresearch.com/report-global-controlled-drug-delivery-market-and-clinical-trial-outlook-2022.php

Report Table of Contents

1 Drug Delivery: An Advancing Trajectory
1.1 Preface Towards Drug Delivery
1.2 Idealism of Drug Delivery System

2. Introduction to Controlled Drug Delivery
2.1 Novel Drug Delivery Systems
2.2 Preamble to Controlled Drug Delivery

3. Evolution of Controlled Drug Delivery
3.1 First Generation
3.2 Second Generation

4. Fundamentals of Controlled Drug Delivery
4.1 Prerequisites of Controlled Delivery
4.2 Rationale for Controlled Drug Delivery

5. Mechanism of Controlled Drug Release
5.1 Diffusion Controlled
5.2 Dissolution Controlled System
5.3 Water Penetration Controlled System
5.4 Erosion Controlled System
5.5 Ion-Exchange Controlled System

6. Cataloging of Controlled Drug Delivery
6.1 Classification Based Over Delivery Systems
6.2 Classification Based Over Technicality
6.3 Classification Based Over Routes

7. Approaches for Controlled Drug Delivery
7.1 Polymers
7.2 Chronopharmaceutics
7.3 Nanoparticulate Delivery System

8. Global Controlled Release Drug Clinical Pipeline Overview
8.1 Phase
8.2 Country/Region
8.3 Mode of Action
8.4 Drug class
8.5 Indication

9. Application of Controlled Drug Delivery
9.1 Diabetes
9.2 Cancer
9.3 Cardiovascular Diseases
9.4 Neurological Disorders
9.5 Infections

10. Drug Designing for Controlled Delivery
10.1 Enteral Dosage Formulations
10.1.1 Solid Dosage Forms
10.1.2 Liquid Dosage Forms
10.1.3 Inhalation Dosage Forms
10.2 Parenteral Dosage Forms
10.2.1 Injectable Dosage Forms
10.2.2 Implantable Device
10.3 General Mechanisms of Drug Release

11. Market Inclinations
11.1 Market over Routes of Administration
11.2 Market over Approaches

12. Global Controlled Drug Delivery Market Dynamics
12.1 Accelerative Parameters
12.2 Challenges

13. Global Controlled Drug Delivery Market Future Outlook
13.1 Ongoing Clinical Trials
13.2 Future Market Opportunities

14. Global Controlled Drug Delivery Clinical Trials by Company, Indication and Phase
14.1 Unknown
14.2 Research
14.3 Preclinical
14.4 Clinical
14.5 Phase-I
14.6 Phase-I/II
14.7 Phase-II
14.8 Phase-II/III
14.9 Phase-III
14.10 Preregistration
14.11 Registered

15. Marketed Controlled Release Clinical Insight by Company, Indication and Phase

16. Competitive Landscape
16.1 Allergan
16.2 Amylin Pharmaceuticals
16.3 AstraZeneca
16.4 BioAlliance Pharma
16.5 Biogen
16.6 Collegium Pharmaceutical
16.7 Controlled Therapeutics (Ferring Pharmaceuticals)
16.8 Cosmo Pharmaceuticals
16.9 Egalet
16.10 Elan Corporation
16.11 Encore Therapeutics
16.12 Flamel Technologies
16.13 GlaxoSmithKline
16.14 Heron Therapeutics
16.15 iCeutica
16.16 Mithra Pharmaceuticals
16.17 Neurim Pharmaceuticals
16.18 Novartis
16.19 Orexigen Therapeutics
16.20 Otsuka Pharmaceutical
16.21 Pfizer
16.22 Purdue Pharma
16.23 Syntex Pharmaceuticals International
16.24 Takeda
16.25 Zealand Pharma

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Controlled Drug Delivery Market & Controlled Drug Delivery Clinical Trial Outlook 2022 here

News-ID: 613320 • Views:

More Releases from Kuick Resarch

Bispecific Antibody Drug Conjugates Development
Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,
Breakthroughs in KRAS Inhibitor Research
Breakthroughs in KRAS Inhibitor Research
KRAS mutations have posed a significant challenge in oncology for decades, but recent breakthroughs in KRAS inhibitor research have sparked hope for new cancer therapies. KRAS is a key regulator of cell growth and survival, and its mutations are prevalent in various cancers, particularly lung, colorectal, and pancreatic cancers. Despite being one of the most sought-after targets, KRAS has been notoriously difficult to inhibit, earning the reputation of being "undruggable." Download
Lumakras Drug Clinical Insight and Sales Forecast 2026
Lumakras Drug Clinical Insight and Sales Forecast 2026
"Lumakras Drug Clinical Insight and Sales Forecast 2026" Report Highlights: * NSCLC Targeting Lumakras Market Opportunity (US$ Million) * Colorectal Cancer Targeting Lumakras Market Opportunity (US$ Million) * Pharmacokinetics of Lumakras (Sotorasib) * Dosage, Patent and Price Analysis * Lumakras Ongoing Clinical Trials * Global KRAS Protein Inhibitors Clinical Trials Download Report: https://www.kuickresearch.com/report-lumakras-sotorasib-sales-forecast-fda-approved-kras-inhibitor-clinical-trials-non-small-cell-lung-cancer-nslc-g12c-mutation-c30h30f2n6o3-ras-gtpase The rising burden of cancer and the increasing cancer mortality rates possesses an unmet need for the development of novel therapies in the management
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
"Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026" Report Highlights: * Global EZH2 Inhibitor Market Opportunity > US$ 1.2 Billion by 2026 * Tazverik (Tazemetostat) First Approved EZH2 Inhibitor Drug * Dosage, Price and Sales Analysis of Tazverik * Tazverik Sales Opportunity > US$ 900 Million by 2026 * Tazverik Sales Forecast 2021 Till 2026 * EZH2 Inhibitor Clinical Pipeline Overview By Company, Indication and Phase * EZH2 Inhibitor in Clinical Trials: 7 Drugs Download

All 5 Releases


More Releases for Controlled

Controlled Atmosphere Storage Using a DataTaker
DT80 Provides Single Solution & Saves Money A company contacted CAS DataLoggers with a controlled atmosphere storage environment project as part of pilot testing for a new process. To reduce costs, existing equipment was used wherever possible. The hostile atmosphere produced was found to be incompatible with available humidity sensor technologies, requiring these measurements to be derived in real time using measurements from secondary sensors. The price of logging different sensors
Temperature Controlled Packaging Systems Market
This report presents the worldwide Temperature Controlled Packaging Systems market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis. Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-temperature-controlled-packaging-systems-2025-971 The Temperature Controlled
Achieving Controlled Nucleation During Aseptic Lyophilization
Controlled nucleation is essential for obtaining high-quality lyophilized products with intra- and inter-batch consistency. Two approaches to achieving controlled nucleation have been investigated recently: creating a pressure differential and using an ice fog to insert seed crystals into the vials within the lyophilization chamber. Morrisa Jones, Senior Scientist, Vaccine Drug Product Development Merck, who is speaking at the SMi’s Groups’ Lyophilization USA Conference she will be comparing and contrasting two
Sensor Controlled Vehicle Market 2017-2022
This report splits Sensor Controlled Vehicle By Recommended Age, By Price, By Cruise Speed, By Output Power, By Rated Voltage. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. And this report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside
Controlled Drug Delivery Market Controlled Drug Delivery Clinical Pipeline Repor …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1 Drug Delivery: An Advancing Trajectory 1.1 Preface Towards Drug Delivery 1.2 Idealism of Drug Delivery System 2. Introduction to Controlled Drug Delivery 2.1 Novel Drug Delivery Systems 2.2 Preamble to Controlled Drug Delivery 3. Evolution of Controlled Drug Delivery 3.1 First Generation 3.2 Second Generation 4. Fundamentals of Controlled Drug Delivery 4.1 Prerequisites
New AC axial fan - temperature-controlled
In many applications it is required to use a temperature-controlled axial fan. These fans rotate at low temperature with low speed, resulting in energy savings and less noise. If the temperature rises, there is also an increasing speed of the fan and thus lead to much more airflow. So far, only DC axial fans were available. From now on, a 230V AC axial fan in the dimensions 119x119x38mm can be